Biodegradable stents, which are made of various synthetic polymers, such as polylactide or polyglycolide, or co-polymers, such as polydioxanone, can be used for the treatment of benign refractory stenoses of the gastrointestinal tract. Here we report 11 patients (median age 41) with stenosing Crohn’s disease of the small and/or large intestine. Endoscopic insertion of a biodegradable stent was successful at the first attempt in all patients except one. Subsequent follow-up was for a mean of 16 months, median 17 months, range 12 – 29 months. Early stent migration (between 2 days and 8 weeks) was seen in three patients. Mucosal overgrowth (epithelial hyperplasia) was not observed in any of the patients during the follow-up period. The high rate of early stent migration might be solved by appropriate tailoring and further improvements in the design of the biodegradable stents. Proof of long-term efficacy and safety requires further studies.
References
1
McLoughlin M T, Byrne M F.
Endoscopic stenting – where we are now and where can we go?.
World J Gastroenterol.
2008;
14
3798-3803
2
Siersema P D.
Stenting for benign esophageal strictures.
Endoscopy.
2009;
41
363-373
3
Chun H J, Kim E S, Hyun J J et al.
Gastrointestinal and biliary stents.
J Gastroenterol Hepatol.
2010;
25
234-243
4
Freeman M L.
Bioabsorbable stents for gastrointestinal endoscopy.
Tech Gastrointest Endosc.
2001;
3
120-125
5
Bickston S J, Foley E, Lawrence C et al.
Terminal ileal stricture in Crohn’s disease: treatment using a metallic enteral endoprosthesis.
Dis Colon Rectum.
2005;
48
1081-1085
6
Kita H, Yamamoto H.
Double-balloon endoscopy for the diagnosis and treatment of small intestinal disease.
Best Pract Res Clin Gastroenterol.
2006;
20
179-194
7
Tierney W, Chuttani R, Croffie J et al.
Enteral stents.
Gastrointest Endosc.
2006;
63
920-926
8
Judah J R, Draganov P V.
Endoscopic therapy of benign biliary strictures.
World J Gastroenterol.
2007;
13
3531-3539
9
Bhasin D K, Rana S S.
Biodegradable pancreatic stents: are they a disappearing wonder?.
Gastrointest Endosc.
2008;
67
1113-1115
10
Bures J.
Bio-degradable stents. A clever tool to overcome the drawbacks of ”standard treatment“ of refractory stenoses.
Folia Gastroenterol Hepatol.
2009;
7
4-6
Available from:
http://www.pro-folia.org
Accessed: 5 March 2011
11
Fry S W, Fleischer D E.
Management of a refractory benign esophageal stricture with a new biodegradable stent.
Gastrointest Endosc.
1997;
45
179-182
12
Goldin E, Fiorini A, Ratan Y et al.
A new biodegradable and self-expandable stent for benign esophageal strictures.
Gastrointest Endosc.
1996;
43
294
13
Tanaka T, Takahashi M, Nitta N et al.
Newly developed biodegradable stents for benign gastrointestinal tract stenoses: a preliminary clinical trial.
Digestion.
2006;
74
199-205
14
Saito Y, Tanaka T, Andoh A et al.
Usefulness of biodegradable stents constructed of poly-l-lactic acid monofilaments in patients with benign esophageal stenosis.
World J Gastroenterol.
2007;
13
3977-3980
15
Saito Y, Tanaka T, Andoh A et al.
Novel biodegradable stents for benign esophageal strictures following endoscopic submucosal dissection.
Dig Dis Sci.
2008;
53
330-333
16
Bychkova O V, Lazyuk I I, Averin V.
Bio-degradable stents – new approach to the treatment of caustic stenoses in children.
Folia Gastroenterol Hepatol.
2009;
7
30-34
Available from:
http://www.pro-folia.org
Accessed: 5 March 2011
17
Dhar A, Topping J H, Johns E, O’Neill D.
Biodegradable stents in refractory benign oesophageal strictures – first report of 4 patients from UK.
Gastrointest Endosc.
2009;
69
AB254-AB255
18
Vandenplas Y, Hauser B, Devreker T et al.
A biodegradable esophageal stent in the treatment of a corrosive esophageal stenosis in a child.
J Pediatr Gastroenterol Nutr.
2009;
49
254-257
19
Stivaros S M, Williams L R, Senger C et al.
Woven polydioxanone biodegradable stents: a new treatment option for benign and malignant oesophageal strictures.
Eur Radiol.
2010;
20
1069-1072
20
Repici A, Vleggaar F P, Hassan C et al.
Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study.
Gastrointest Endosc.
2010;
72
927-934
21
Parviainen M, Sand J, Harmoinen A et al.
A new biodegradable stent for the pancreaticojejunal anastomosis after pancreaticoduodenal resection: in vitro examination and pilot experiences in humans.
Pancreas.
2000;
21
14-21
22
Petrtyl J, Bruha R, Horak L et al.
Management of benign intrahepatic bile duct strictures: initial experience with polydioxanone biodegradable stents.
Endoscopy.
2010;
42 (Suppl. 2)
E89-E90
23
Laukkarinen J, Sand J, Leppiniemi J et al.
A novel technique for hepaticojejunostomy for nondilated bile ducts: a purse-string anastomosis with an intra-anastomotic biodegradable biliary stent.
Am J Surg.
2010;
200
124-130
24
Rejchrt S, Kopacova M, Bartova J, Bures J.
Intestinal biodegradable stents. Initial experience in the Czech Republic.
Folia Gastroenterol Hepatol.
2009;
7
7-11
Available from:
http://www.pro-folia.org
Accessed: 5 March 2011
25 England R. Case study: Implant of SX-ELLA BD biodegradable stent in patient with post radiotherapy benign oesophageal stricture. BD Clinical Bulletin A44pp.. Sheffield: UK Medical Limited; 2008. Available from: http://www.ukmedical.com/catalogue/stenting/non-vascular-stenting/hv-stent.htm. Accessed 5 March 2011
26
Kopacova M, Bures J, Vykouril L et al.
Intraoperative enteroscopy: ten years’ experience at a single tertiary center.
Surg Endosc.
2007;
21
1111-1116
27
Kopacova M, Rejchrt S, Tacheci I, Bures J.
Hyperamylasemia of uncertain significance associated with oral double-balloon enteroscopy.
Gastrointest Endosc.
2007;
66
1133-1138
28
Rejchrt S, Kopacova M, Tacheci I, Bures J.
Interventional double balloon endoscopy for Crohn’s, gastrointestinal bleeding, and foreign body extraction.
Tech Gastrointest Endosc.
2008;
10
101-106
29
Freudenberg S, Rewerk S, Kaess M et al.
Biodegradation of absorbable sutures in body fluids and pH buffers.
Eur Surg Res.
2004;
36
376-385
30
Gunatillake P, Mayadunne R, Adhikari R.
Recent developments in biodegradable synthetic polymers.
Biotechnol Annu Rev.
2006;
12
301-347
31
Orive-Calzada A, Alvarez-Rubio M, Romero-Izquierdo S et al.
Severe epithelial hyperplasia as a complication of a novel biodegradable stent.
Endoscopy.
2009;
41 (Suppl. 2)
E137-E138
32
Hair C S, Devonshire D A.
Severe hyperplastic tissue stenosis of a novel biodegradable esophageal stent and subsequent successful management with high-pressure balloon dilation.
Endoscopy.
2010;
42 (Suppl. 2)
E132-E133
S. RejchrtMD, PhD
2nd Department of Internal Medicine University Teaching Hospital
Sokolska 581 50005 Hradec Kralove Czech Republic
Fax: +420-495-834785
eMail: rejchrt@lfhk.cuni.cz